Herbert I. Hurwitz

Duke University

Full Professor(heuristic)

Colorectal Cancer Treatments and Studies · Oncology

h-index80

i10-index229

Publications544

Citations35,747

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 14 of 14

Phase Ib/ <scp>II</scp> study of Pembrolizumab with Lanreotide depot for advanced, progressive Gastroenteropancreatic neuroendocrine tumors ( <scp>PLANET</scp> )
Journal of Neuroendocrinology · 2025-02-11 · 6 citations
Data from Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy ParticipantsPreprint
2025-01-09
Supplementary Table S4 from Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants
2025-01-09
Supplementary Figure S3 from Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy ParticipantsPreprint
2025-01-09
Supplementary Table S1 from Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants
2025-01-09
Supplementary Table S5 from Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants
2025-01-09
Supplementary Figure S2 from Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy ParticipantsPreprint
2025-01-09
Supplementary Figure S1 from Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy ParticipantsPreprint
2025-01-09
Supplementary Table S2 from Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants
2025-01-09
Supplementary Table S3 from Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants
2025-01-09
Author response for "Phase Ib/<scp>II</scp> study of Pembrolizumab with Lanreotide depot for advanced, progressive Gastroenteropancreatic neuroendocrine tumors (<scp>PLANET</scp>)"
2024-11-28
Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants
Cancer Epidemiology Biomarkers & Prevention · 2024-10-14
A causal inference framework for leveraging external controls in hybrid trials
Biometrics · 2024-10-03 · 3 citations
Causal estimators for incorporating external controls in randomized trials with longitudinal outcomes
Journal of the Royal Statistical Society Series A (Statistics in Society) · 2024-08-26 · 3 citations

Open author page on OpenAlex →